Pharmaceutical and Device PhRMA Submits Comments on 340B Program Stability Thomas Sullivan Sep 20, 2023 0 Recently, the Pharmaceutical Research and Manufacturers of America (PhRMA) submitted comments in response to the Senate 340B…
